Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.
J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27.
J Am Soc Nephrol. 2017.
PMID: 27352623
Free PMC article.
Clinical Trial.